[Evaluation of the effectiveness of treatment of border-line neuropsychiatric disorders with amytal-caffeine].
D000293:Adolescent; D000328:Adult; D000654:Amobarbital / Q000627:therapeutic use*; D002110:Caffeine / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*
D004338:Drug Combinations; D002110:Caffeine; D000654:Amobarbital
Otsenka effektivnosti lecheniia amital-kofeinom pogranichnykh nervno-psikhicheskikh rasstroistv